Delivery Order SPE2DX16D9411-SPE2DX25FEPAD

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,034.56 by the Defense Logistics Agency's Medical Supply Chain division on September 8, 2025. The delivery order, which carries no set-aside designation, is expected to be completed by September 10, 2025, and represents a task order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. This delivery order is part of the company's broader $499,999,999 single-award IDC with the DLA under the SPE2DB program, which remains valid through November 2026 and enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.

As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's contract portfolio encompasses an extensive array of products including prescription medications, vaccines, injections, contraceptive devices, oncology treatments, and specialty pharmaceuticals. This particular delivery order continues the company's consistent performance under the Defense Logistics Agency's pharmaceutical procurement framework, leveraging its established capabilities and woman-owned small business status to support military medical supply requirements.